dc.description.abstract | Although acupuncture (AT) is used in the treatment of CRF, the evidence from different
systematic reviews (SRs) of AT has not yet been comprehensively evaluated. Moxibustion, which is a
treatment method that is well established within Traditional East Asian Medicine, applies the heat of
burning herbs towards or onto special points on the skin. Commonly, the herb Artemisia vulgaris,
is used. It has been used for palliative cancer care, as well as for CRF. The aim of this overview
was to evaluate the efficacy of AT and moxibustion in the management of CRF. Eleven databases
were searched through for studies that were published from their dates of inception to February
2022. The study selection, the data extraction, and the assessment were performed independently by
two researchers. The methodological and report quality were assessed by using the Assessment of
Multiple Systematic Reviews-2 (AMSTAR-2) tool. The evidence quality was evaluated by using the
Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Fifteen
SRs on AT (n = 10) and moxibustion (n = 5) treatments for CRF were included, and they include
169 randomized controlled trials and 14,392 participants. All of the SRs that were evaluated by
the AMASTAR-2 had more than one deficiency, and so all of the SRs were rated as either low or
critically low. For the GRADE, 18 outcomes were rated as very-low-quality evidence, 13 as lowquality evidence, 3 as moderate-quality evidence, and 0 as high-quality evidence. Most of the SRs
reached the potential benefits of AT for CRF. No serious adverse effects were identified. In conclusion,
the evidence suggests that, despite the advantages of AT in terms of the improvement in and the
safety of the treatment of CRF, the methodological quality of most of these studies is low, which
limits our ability to draw definitive meanings. Further research of high quality is needed in order to
confirm these findings. | en_US |